CN104094924A - Cryoprotectant for human sperm - Google Patents

Cryoprotectant for human sperm Download PDF

Info

Publication number
CN104094924A
CN104094924A CN201310172542.2A CN201310172542A CN104094924A CN 104094924 A CN104094924 A CN 104094924A CN 201310172542 A CN201310172542 A CN 201310172542A CN 104094924 A CN104094924 A CN 104094924A
Authority
CN
China
Prior art keywords
sperm
caffeine
cyclodextrin
fructose
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310172542.2A
Other languages
Chinese (zh)
Inventor
李铮
刘锋
刘勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310172542.2A priority Critical patent/CN104094924A/en
Publication of CN104094924A publication Critical patent/CN104094924A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a cryoprotectant for a human sperm. The cryoprotectant comprises aseptic deionized water, fresh yolk, glycerin, sodium citrate, glucose, fructose, caffeine and cyclodextrin, wherein a volume ratio of deionized water to fresh yolk to glycerin is 5: 1: 1, and a mass ratio of fresh yolk to glycerin to sodium citrate to glucose to fructose to caffeine to cyclodextrin is 0.2 mg/ml: 0.15 mg/ml: 13 mg/ml: 10 mg/ml: 5 mg/ml: 1 mg/ml: 1 mg/ml. A preparation method for the cryoprotectant comprises the following steps: filling a container with 100 ml of aseptic deionized water; then successively adding 1.22 g of sodium citrate, 0.78 g of glucose, 0.68 g of fructose, 20 ml of fresh yolk, 20 ml of glycerin, 0.5 g of caffeine and 0.5 g of cyclodextrin; and finally, uniformly mixing all the above-mentioned raw materials, putting the obtained mixture in a water bath with a temperature of 56 DEG C for 30 min for inactivation, carrying out cooling, then carrying out filtering and split charging and standing the obtained cryoprotectant for subsequent usage. According to the invention, the sperm can be better protected through a novel formula; on the basis of conventional cryoprotectants for the human sperm, the post-thawing and recovery rate of the human sperm is increased, and the original functions of the sperm are better maintained.

Description

A kind of human sperm's cryoprotector
Technical field
The present invention relates to technical field of bioengineering, particularly a kind of human sperm's cryoprotector.
Background technology
Human sperm's freezing preservation has positive effect for human reproduction's health, and one of key factor that affects controlled-rate freezing is the cryoprotector adding in refrigerating process.
At human sperm bank, human sperm's freezing preservation has had very ripe reagent and technology, and for the preservation of other cells, sperm storage more must be preserved its energy and fertility when keeping its activity ratio.
The chief component of domestic conventional cryoprotector is yolk and glycerine at present, and external commercialization cryoprotector chief component is albumin and glycerine.In general the ratio of yolk and glycerine is 10%-15%, and the ratio of yolk is 15%-20%, uses these two kinds of cryoprotectors can make the Cryopreservation rate of sperm be stabilized in 60%-70%, can reach the requirement of the Ministry of Public Health to sperm bank.But for each reproductive center, auxiliary procreation technology needs the sperm that energy is better, function is more complete.
Summary of the invention
The defect existing in order to overcome above-mentioned prior art, the invention provides a kind of sperm freezing protecting agent, by new formula, better protects sperm, on existing human sperm's cryoprotector basis, has improved Cryopreservation rate, keeps better sperm original function.
To achieve these goals, technical scheme of the present invention is as follows:
A kind of human sperm's cryoprotector; comprise that volume ratio is the aseptic ionized water of 5: 1: 1, fresh yolk and glycerine; also comprise sodium citrate, glucose, fructose, caffeine and cyclodextrin; its quality proportion relation is:: fresh yolk 0.2mg/ml; glycerine 0.15mg/ml, sodium citrate 13mg/ml, glucose 10mg/ml, fructose 5mg/ml, caffeine 1mg/ml and cyclodextrin 1mg/ml.。
Its collocation method is as described below:
First, with the aseptic ionized water of container splendid attire 100ml.
Then, successively add successively 1.22g sodium citrate, 0.78g glucose, 0.68g fructose, the fresh yolk of 20ml, 20ml glycerine, 0.5g caffeine and 0.5g cyclodextrin.
Final step is, after above-mentioned each raw material is mixed, puts the deactivation in 30 minutes of 56 ℃ of water baths, after cooling, filters packing finished product, stand-by.
The invention has the beneficial effects as follows; before comparing, sperm freezing protecting agent is a kind of brand-new formula; method is novel; on existing human sperm's cryoprotector basis; improved Cryopreservation rate; keep better sperm original function, can provide the sperm that energy is better, function is more complete for reproductive center.
Embodiment:
In order to make technological means of the present invention, creation characteristic and to reach object, be easy to understand understanding, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment:
A kind of sperm freezing protecting agent of the present invention; comprise that volume ratio is the aseptic ionized water of 5: 1: 1, fresh yolk and glycerine; also comprise sodium citrate, glucose, fructose, caffeine and cyclodextrin; its quality proportion relation is:: fresh yolk 0.2mg/ml; glycerine 0.15mg/ml, sodium citrate 13mg/ml, glucose 10mg/ml, fructose 5mg/ml, caffeine 1mg/ml and cyclodextrin 1mg/ml.。
Its collocation method is as described below:
First, with the aseptic ionized water of container splendid attire 100ml.
Then, successively add successively 1.22g sodium citrate, 0.78g glucose, 0.68g fructose, the fresh yolk of 20ml, 20ml glycerine, 0.5g caffeine and 0.5g cyclodextrin.
Final step is, after above-mentioned each raw material is mixed, puts the deactivation in 30 minutes of 56 ℃ of water baths, after cooling, filters packing finished product, stand-by.
The effect of above-mentioned each constitutive material composition is: add 1.22g sodium citrate, for maintaining protectant acid base equilibrium; Add 0.78g glucose, for spermoblast film, have protective effect; Adding 0.68g fructose, is the nutriment of sperm; Add the fresh yolk of 20ml, protection perforatorium, improves sperm motility rate.
Add 20ml glycerine, permeable mass, can infiltrate in sperm membrane, the infringement that the minimizing ice crystal phase causes sperm; Add 0.5g caffeine, can significantly improve vigor and the rate in vitro fertilization of sperm; Add 0.5g cyclodextrin, anti-oxidant, protection plasmalemmae of sperms and acrosomal integnity.
More than show and described basic principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; that in above-described embodiment and specification, describes just illustrates principle of the present invention; the present invention also has various changes and modifications without departing from the spirit and scope of the present invention, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.

Claims (2)

1. human sperm's cryoprotector; it is characterized in that; comprise that volume ratio is the aseptic ionized water of 5: 1: 1, fresh yolk and glycerine; also comprise sodium citrate, glucose, fructose, caffeine and cyclodextrin; its quality proportion relation is:: fresh yolk 0.2mg/ml; glycerine 0.15mg/ml, sodium citrate 13mg/ml, glucose 10mg/ml, fructose 5mg/ml, caffeine 1mg/ml and cyclodextrin 1mg/ml.。
2. a kind of human sperm's cryoprotector according to claim 1, is characterized in that, its collocation method is as described below:
(1) first, with the aseptic ionized water of container splendid attire 100ml;
(2) then, successively add successively 1.22g sodium citrate, 0.78g glucose, 0.68g fructose, the fresh yolk of 20ml, 20ml glycerine, 0.5g caffeine and 0.5g cyclodextrin.
(3) final step is, after above-mentioned each raw material is mixed, puts the deactivation in 30 minutes of 56 ℃ of water baths, after cooling, filters packing finished product, stand-by.
CN201310172542.2A 2013-04-13 2013-04-13 Cryoprotectant for human sperm Pending CN104094924A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310172542.2A CN104094924A (en) 2013-04-13 2013-04-13 Cryoprotectant for human sperm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310172542.2A CN104094924A (en) 2013-04-13 2013-04-13 Cryoprotectant for human sperm

Publications (1)

Publication Number Publication Date
CN104094924A true CN104094924A (en) 2014-10-15

Family

ID=51663760

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310172542.2A Pending CN104094924A (en) 2013-04-13 2013-04-13 Cryoprotectant for human sperm

Country Status (1)

Country Link
CN (1) CN104094924A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104365583A (en) * 2014-11-07 2015-02-25 郜鸿生物科技(上海)有限公司 Extremely-low sperm freezing protective agent and application thereof
CN108651440A (en) * 2018-04-18 2018-10-16 中南大学 A kind of supper-fast freezen protective system of human seminal fluid
EP3284795A4 (en) * 2015-04-16 2019-03-20 The School Corporation Kansai University Anti-ice nucleation activator
KR102364057B1 (en) * 2021-01-26 2022-02-17 한국식품연구원 Method for microorganism cryoprotectant using coffee residue
KR102463256B1 (en) * 2022-05-02 2022-11-07 주식회사 프롬바이오 Composition for Low-temperatuer Preservation or Cryopreservation of Fat Tissue Using Caffeine, etc. and the Preservation Method of Fat Tissue Using the Same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104365583A (en) * 2014-11-07 2015-02-25 郜鸿生物科技(上海)有限公司 Extremely-low sperm freezing protective agent and application thereof
CN104365583B (en) * 2014-11-07 2016-08-24 郜鸿生物科技(上海)有限公司 A kind of rare sperm freezing protecting agent and application thereof
EP3284795A4 (en) * 2015-04-16 2019-03-20 The School Corporation Kansai University Anti-ice nucleation activator
US10633570B2 (en) 2015-04-16 2020-04-28 The School Corporation Kansai University Anti-ice nucleation activator
CN108651440A (en) * 2018-04-18 2018-10-16 中南大学 A kind of supper-fast freezen protective system of human seminal fluid
KR102364057B1 (en) * 2021-01-26 2022-02-17 한국식품연구원 Method for microorganism cryoprotectant using coffee residue
KR102463256B1 (en) * 2022-05-02 2022-11-07 주식회사 프롬바이오 Composition for Low-temperatuer Preservation or Cryopreservation of Fat Tissue Using Caffeine, etc. and the Preservation Method of Fat Tissue Using the Same

Similar Documents

Publication Publication Date Title
CN104094924A (en) Cryoprotectant for human sperm
JP2015061520A5 (en)
WO2017139908A1 (en) Small ruminant semen freezing diluent
CN104663649A (en) Human ovocyte cryoprotectant
CN103749658A (en) Cherry preservative
CN102640745A (en) Ultralow-temperature cryopreservation and recovery method for embryonic materials
CN107047542A (en) A kind of serum-free cell frozen stock solution
CN104555951B (en) A kind of method utilizing cryogenic technique preparation and preservation nanometer selenium
CN102308873B (en) Orange antistaling agent, its preparation method and application
Fuller et al. Organ preservation solutions: linking pharmacology to survival for the donor organ pathway
CN107232185A (en) A kind of equus oocyte vitrification freezen protective liquid, freezing and storing method and application
CN111771874A (en) Cryopreservation method for substances such as autologous adipose cell cryopreservation liquid and adipose mesenchymal stem cells
CN112167243A (en) Erythrocyte cryopreservation liquid and rapid cryopreservation method
CN104224746A (en) Hollow plant capsule and preparation method thereof
CN107926929A (en) A kind of Cryopreservation of Sungkiang weever sperm
CN102524243A (en) Preservative for fresh flower
CN106689970A (en) Green tea preservative with no toxic or side effect and processing technique thereof
CN114190368B (en) Serum-free immune cell cryopreservation liquid, preparation method and immune cell cryopreservation method
CN103478119A (en) Cut flower preservative
CN100582221C (en) Ultra low temperature freezing-storage method for onosma paniculatum cell
CN113812401A (en) Transportation preservation liquid and preservation method for umbilical cord mesenchymal stem cells
CN103651763B (en) Method for inhibiting rot of fruits and vegetables in storage period by use of synergistic effect of nitric oxide and hydrogen sulfide
CN105950567A (en) Preservation method for freeze-dried powder capsules of bacteriophage
CN103329990B (en) Nanotitanium dioxide-based fruit fresh-keeping composite and fresh keeping method
CN104255705B (en) One overcomes the vitrified method of regrowth after jerusalem artichoke stem apex Excised Embryos

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141015